↑ Rising
Business
Pfizer Covid Pill Revenue Plunges 95%. Why Earnings Are Lifting the Stock Anyway.
Pfizer's stock is rising after beating earnings estimates, despite a 95% plunge in revenue from its Covid pill.
1 trends tracked about this subject — the full history, oldest to newest below.
Pfizer's stock is rising after beating earnings estimates, despite a 95% plunge in revenue from its Covid pill.